Understanding the Effect Size of Lisdexamfetamine Dimesylate for Treating ADHD in Children and Adults
- 13 September 2010
- journal article
- research article
- Published by SAGE Publications in Journal of Attention Disorders
- Vol. 16 (2) , 128-137
Abstract
Objective: An earlier meta-analysis of pediatric clinical trials indicated that lisdexamfetamine dimesylate (LDX) had a greater effect size than other stimulant medications. This work tested the hypothesis that the apparent increased efficacy was artifactual. Method: The authors assessed two potential artifacts: an unusually high precision of measurement and an unusually low placebo effect. The authors evaluated generalizability from children of adults. Results: The LDX effect sizes for children were significantly larger than the pooled stimulant effect sizes from studies using the same outcome measures. However, although no other individual stimulant study had an effect size greater than LDX, there was overlap between the 95% confidence intervals for some of these studies and the LDX study. The high LDX effect sizes were not due measurement or placebo effect artifacts. LDX effect sizes for adults were not larger than the stimulant effect sizes from other studies. Conclusion: The high LDX effect size for children could not attributed to measurement artifacts. The superiority of LDX in the pediatric clinical trial reflected the greater efficacy of amphetamine products, compared with methylphenidate products but required replication in children because (a) the results were based on only one trial of LDX in children, and (b) the finding did not generalize to adults.Keywords
This publication has 39 references indexed in Scilit:
- Comparing the efficacy of stimulants for ADHD in children and adolescents using meta-analysisEuropean Child & Adolescent Psychiatry, 2009
- A 13-hour laboratory school study of lisdexamfetamine dimesylate in school-aged children with attention-deficit/hyperactivity disorderChild and Adolescent Psychiatry and Mental Health, 2009
- Lisdexamfetamine dimesylate: the first long-acting prodrug stimulant treatment for attention deficit/hyperactivity disorderExpert Opinion on Pharmacotherapy, 2008
- Relative Benefits of Stimulant Therapy With OROS Methylphenidate Versus Mixed Amphetamine Salts Extended Release in Improving the Driving Performance of Adolescent Drivers With Attention-Deficit/Hyperactivity DisorderPediatrics, 2006
- Comparison of the clinical efficacy of twice-daily Ritalin® and once-daily Equasym™ XL with placebo in children with Attention Deficit/Hyperactivity DisorderEuropean Child & Adolescent Psychiatry, 2006
- Methyiphenidate vs. amphetamine: Comparative reviewJournal of Attention Disorders, 2000
- Response to methylphenidate in boys with attention‐deficit hyperactivity disorderActa Paediatrica, 1999
- Classroom Academic Performance: Improvement with both Methylphenidate and Dextroamphetamine in ADHD BoysJournal of Child Psychology and Psychiatry, 1993
- Which boys respond to stimulant medication? A controlled trial of methylphenidate in boys with disruptive behaviourPsychological Medicine, 1987
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986